Panagiotis Efentakis

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

Ioanna Andreadou, Panagiotis Efentakis, Evangelos Balafas et al. · Frontiers in Physiology · 2017 · 148 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Cell Death +28

Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin

Panagiotis Efentakis, Georgios Kremastiotis, Aimilia Varela et al. · Blood · 2018 · 113 citations · Full text

Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms

Athanasia Chatzianastasiou, Sophia-Iris Bibli, Ioanna Andreadou et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 90 citations · Full text

Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress

Panagiota Nikolaou, Panagiotis Efentakis, Fairouz Abu Qourah et al. · Antioxidants and Redox Signaling · 2020 · 71 citations

<i>Aestivation</i>motifs explain hypertension and muscle mass loss in mice with psoriatic skin barrier defect

Johannes Wild, Rebecca Jung, Tanja Knopp et al. · Acta Physiologica · 2021 · 55 citations · Full text